Arrhythmias & electrophysiology

Machine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators

J Am Coll CardiolPublished Prognostic model development and external validation study

Authors' conclusion

The RF-SLAM algorithm accurately predicted all-cause mortality and death/HF hospitalization at 3 months and 1 year during the first 5 years of device implant, demonstrating good internal and external validity.

Study context

Population
Patients with implantable cardioverter-defibrillators (ICDs) with and without cardiac resynchronization therapy (CRT), first 5 years after device implant
Participants
12,043 vs 1,394
Comparison
Training vs Validation
  • Trainingn = 12,043
  • Validationn = 1,394
Outcome
All-cause mortality and composite of death/HF hospitalization
Follow-up
3 months and 1 year
Methodological detailsmachine learning (random forest, random forest for survival, longitudinal, and multivariate (RF-SLAM)), nationwide training cohort, external validation in a separate nonveteran clinical registry, Median follow-up 3.3 years (training) and 3.6 years (validation)
  • Machine learning (random forest, RF-SLAM)
  • Nationwide training cohort
  • External validation in a separate nonveteran clinical registry
  • Median follow-up 3.3 years (training) and 3.6 years (validation)

Performance

As reported in the abstract

Discrimination of the most accurate models (baseline demographics + time-varying ICD data)

AUC, death at 3 months

0.91

95% CI 0.87–0.94

AUC, death at 1 year

0.80

95% CI 0.78–0.82

AUC, death/heart failure (HF) hospitalization at 3 months

0.81

95% CI 0.79–0.83

AUC, death/HF hospitalization at 1 year

0.71

95% CI 0.70–0.72

Further findings

External validation

High discrimination and good calibration in the validation cohort

Predictor importance

Time-varying physiologic ICD data, especially daily physical activity, had substantial importance in predicting outcomes

Original publication

Machine Learning-Based Prediction of Death and Hospitalization in Patients With Implantable Cardioverter Defibrillators. J Am Coll Cardiol. Published 20 November 2024. doi:10.1016/j.jacc.2024.09.006

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.